Jana T. Kuss

Tamoxifen as initial endocrine therapy for metastatic breast cancer: Long term follow-up of two Piedmont Oncology Association (POA) trials

L. Case, H. Muss, H. Hoen, 1997, Breast Cancer Research and Treatment.